China's Kintor, Zelgen complete financings

Suzhou Kintor Pharmaceuticals Inc. (Suzhou, China) and Suzhou Zelgen Biopharmaceuticals Co. Ltd. (Suzhou, China) each completed financings, raising more than $100 million combined.

Kintor raised RMB288 million ($44.7 million) on Jan. 11 in a series C round led by Green Pine Capital Partners, with participation from Orient Securities Capital Investment, Hangzhou Beijia Investment Management, China Construction Bank Healthcare Investment Fund and Shanghai Broad Resources Investment Management. Existing investors HighLight Capital and Oriza Holdings also participated. ...